ANL logo

ANL
Adlai Nortye Ltd. American

278
Mkt Cap
$390.07M
Volume
19,329.00
52W High
$17.25
52W Low
$0.8786
PE Ratio
-11.29
ANL Fundamentals
Price
$11.72
Prev Close
$11.36
Open
$11.51
50D MA
$11.44
Beta
0.00
Avg. Volume
716,300.65
EPS (Annual)
-$1.11
P/B
-54.60
Rev/Employee
$45,992.88
$47.99
Loading...
Loading...

About

Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
109

Frequently Asked Questions

What is Market Cap of Adlai Nortye Ltd. - ADR?
What is the 52-week high for Adlai Nortye Ltd. - ADR?
What is the 52-week low for Adlai Nortye Ltd. - ADR?
What is Adlai Nortye Ltd. - ADR stock price today?
What was Adlai Nortye Ltd. - ADR stock price yesterday?
What is the PE ratio of Adlai Nortye Ltd. - ADR?
What is the Price-to-Book ratio of Adlai Nortye Ltd. - ADR?
What is the 50-day moving average of Adlai Nortye Ltd. - ADR?
How many employees does Adlai Nortye Ltd. - ADR have?

Latest ANL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.